Published in J Urol on January 19, 2011
Short-term outcomes of vaginal mesh placement among female Medicare beneficiaries. Urology (2014) 1.47
Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention. Urology (2015) 1.40
The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: a systematic review. Int Urogynecol J (2012) 1.11
Epidemiological trends and future care needs for pelvic floor disorders. Curr Opin Obstet Gynecol (2015) 0.89
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of care. Curr Urol Rep (2012) 0.89
Understanding the dissemination of sacral neuromodulation. Surg Innov (2013) 0.84
Predictors of implantable pulse generator placement after sacral neuromodulation: who does better? Neuromodulation (2013) 0.84
Battery explantation after sacral neuromodulation in the Medicare population. Neurourol Urodyn (2012) 0.80
Concerns regarding sacral neuromodulation as a treatment option for medical-refractory overactive bladder. Can Urol Assoc J (2011) 0.76
The effect of sacral neuromodulation on anticholinergic use and expenditures in a privately insured population. Neuromodulation (2013) 0.75
Outcomes of Sacral Neuromodulation in a Privately Insured Population. Neuromodulation (2016) 0.75
Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol (2007) 3.61
Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology (2005) 1.90
Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol (1999) 1.88
Incidence and predictors of complications with sacral neuromodulation. Urology (2009) 1.69
Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol (2001) 1.54
Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol (2007) 1.41
Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol (2006) 1.31
Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience. Neurourol Urodyn (2007) 1.28
Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review. Neurourol Urodyn (2010) 1.19
Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol (2007) 1.07
Sacral neuromodulation for the treatment of refractory interstitial cystitis: outcomes based on technique. Int Urogynecol J Pelvic Floor Dysfunct (2003) 1.07
Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Eur Urol (2006) 1.06
Sacral neuromodulation in an older, urge-incontinent population. Am J Obstet Gynecol (2002) 0.96
Sacral nerve stimulation for refractory overactive bladder in the elderly population. J Urol (2009) 0.93
Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test. World J Urol (2008) 0.91
Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct (2003) 0.87
Sacral neuromodulation in Norway: clinical experience of the first three years. Scand J Urol Nephrol Suppl (2002) 0.83
Sacral neuromodulation for nonobstructive urinary retention--is success predictable? J Urol (2007) 0.81
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Prevalence of kidney stones in the United States. Eur Urol (2012) 9.42
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. J Natl Cancer Inst (2010) 3.24
Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int (2005) 3.13
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol (2011) 3.00
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol (2012) 2.96
Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. JAMA Surg (2014) 2.89
Urologic diseases in America Project: analytical methods and principal findings. J Urol (2005) 2.87
Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol (2011) 2.78
Economic costs of overactive bladder in the United States. Urology (2009) 2.68
Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med (2006) 2.52
Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38
Trends in stricture management among male Medicare beneficiaries: underuse of urethroplasty? Urology (2010) 2.37
Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol (2007) 2.35
Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. Urology (2011) 2.26
Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology (2014) 2.23
Overall survival advantage with partial nephrectomy: a bias of observational data? Cancer (2013) 2.21
Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst (2010) 2.17
Simple cystectomy: outcomes of a new operative technique. Urology (2011) 2.17
Suicidal ideation among patients with bladder pain syndrome/interstitial cystitis. Urology (2012) 2.08
Comparative effectiveness of aggressive versus nonaggressive treatment among men with early-stage prostate cancer and differing comorbid disease burdens at diagnosis. Cancer (2014) 2.07
Compliance with antibiotic prophylaxis in children with vesicoureteral reflux: results from a national pharmacy claims database. J Urol (2010) 2.05
The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol (2006) 2.02
Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study. J Urol (2011) 1.98
Adverse health outcomes associated with surgical management of the small renal mass. J Urol (2013) 1.95
Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis. Cancer (2009) 1.95
Finasteride reduces the risk of incident clinical benign prostatic hyperplasia. Eur Urol (2012) 1.89
Renal and cardiovascular morbidity after partial or radical nephrectomy. Cancer (2008) 1.89
Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol (2013) 1.88
Recurrence of high-risk bladder cancer: a population-based analysis. Cancer (2013) 1.87
Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol (2010) 1.87
Complications requiring reoperation following vaginal mesh kit procedures for prolapse. Am J Obstet Gynecol (2008) 1.77
Variation in continence and potency by definition. J Urol (2003) 1.75
Quality of care in patients with bladder cancer: a case report? Cancer (2011) 1.73
Quality of surveillance for stage I testis cancer in the community. J Clin Oncol (2009) 1.69
Variations in reconstruction after radical cystectomy. Cancer (2006) 1.69
Urinary diversion and morbidity after radical cystectomy for bladder cancer. Cancer (2010) 1.63
The demographic burden of urologic diseases in America. Urol Clin North Am (2009) 1.61
Readmissions in the postoperative period following urinary diversion. World J Urol (2010) 1.59
Emergency department revisits for patients with kidney stones in California. Acad Emerg Med (2015) 1.56
Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer (2014) 1.55
Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer (2011) 1.55
Prostate cancer. J Urol (2007) 1.52
The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. J Urol (2013) 1.52
Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: a population-based sample. Gen Hosp Psychiatry (2011) 1.50
Trends in the surgical management of stress urinary incontinence among female Medicare beneficiaries, 2002-2007. Urology (2013) 1.49
Downstream complications following urinary diversion. J Urol (2013) 1.48
Prevalence and severity of undiagnosed urinary incontinence in women. Am J Med (2009) 1.48
Urologic diseases in North America Project: trends in resource utilization for urinary tract infections in children. J Urol (2005) 1.46
Is availability of endoscopy changing initial management of vesicoureteral reflux? J Urol (2009) 1.46
Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med (2010) 1.45
Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol (2009) 1.45
Quality of care indicators for prostate cancer: progress toward consensus. Urol Oncol (2009) 1.44
Trends in prenatal sonography use and subsequent urologic diagnoses and abortions in the United States. J Pediatr Urol (2009) 1.40
External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res (2009) 1.40
Interstitial cystitis and painful bladder syndrome. J Urol (2007) 1.37
The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination survey. J Urol (2006) 1.36
Regret in men treated for localized prostate cancer. J Urol (2003) 1.35
Trends in surgical management of stress urinary incontinence among female Medicare beneficiaries. Urology (2009) 1.21
Misconceptions and miscommunication among aging women with overactive bladder symptoms. Urology (2010) 1.20
Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol (2010) 1.18
Polypropylene mesh tape for stress urinary incontinence: complications of urethral erosion and outlet obstruction. J Urol (2002) 1.18
Practice variation in the surgical management of urinary lithiasis. J Urol (2011) 1.16
The financial burden of stress urinary incontinence among women in the United States. Curr Urol Rep (2011) 1.13
Surgical quality among Medicare beneficiaries undergoing outpatient urological surgery. J Urol (2012) 1.12
Patterns of pessary care and outcomes for medicare beneficiaries with pelvic organ prolapse. Female Pelvic Med Reconstr Surg (2013) 1.09
Obesity and erectile dysfunction: common problems, common solution? JAMA (2004) 1.08
AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol (2009) 1.07
Marriage and mortality in bladder carcinoma. Cancer (2005) 1.05
Determinants of treatment regret in low-income, uninsured men with prostate cancer. Urology (2008) 1.05
Urologic disease burden in the United States: veteran users of Department of Veterans Affairs healthcare. Urology (2008) 1.04
Kidney cancer. J Urol (2007) 1.02